Mild Cognitive Impairment Clinical Trial
Official title:
Effectiveness of Alternative Therapy for Improving Cognition, Balance, and Physical Activity in Older Adults With Mild Cognitive Deficits for Home or Community-based Translation
Verified date | May 2024 |
Source | University of Illinois at Chicago |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The composite effect of reduced balance, cognition, gait abnormalities/gait disturbances, and physical activity in older adults with mild cognitive impairments (MCI) leads to fear of falling and reduced participation in daily activities, which results in reduced cardiovascular fitness and deconditioning. Although many conventional balance and strength training programs have been implemented for older adults with MCI; these adults do not receive adequate practice dosage to make significant improvements, most likely due to lack of adherence to therapy and/or inadequate incorporation of all domains of the ICF model (body functions and structures, activities and participation) and lack of targeting cognitive-motor interference (deterioration of motor and/or cognitive function when both tasks are performed together). The use of alternative therapies such as dance and virtual reality (VR) has been found to be relatively enjoyable for older adults due to increased motivation, which led to the added improvement of physical and cognitive functioning. The overall aims of this pilot is to test the feasibility of VR-based dance therapy paradigm for older adults with MCI as well as its effect on enhancing balance, gait, and cognition, and physical fitness. Investigators also hope that the net effect of improvement in these domains of health outcomes will result in pre and post reduction of fall risk and improved quality of life of older adults with MCI. The study investigates the effectiveness of a VR (Kinect)-based dance therapy in older adults with MCI by demonstrating its feasibility and compliance rate and also determine the efficacy of the VR-based dance therapy in improving health outcomes such as motor and cognitive functions, thereby reducing cognitive-motor interference. The study will also aim to determine the effectiveness of the VR-based dance paradigm in improving cardiovascular fitness and physical activity (PA) in older adults with MCI
Status | Completed |
Enrollment | 21 |
Est. completion date | December 15, 2022 |
Est. primary completion date | December 15, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 65 Years to 90 Years |
Eligibility | Inclusion Criteria: - Age group: =65 years - Montreal cognitive Assessment (MOCA) score <26/30 - Bone density with a t-score = -2 - Absence of any acute or chronic neurological, cardiopulmonary, musculoskeletal, or systemic diagnosis. - No recent major surgery (< 6 months) - No recent hospitalization (< 3 months) - Not on any sedative drugs - Can understand and communicate in English Exclusion Criteria: - HR > 85% of age-predicted maximal heart rate (HRmax = 220 - age) - Systolic blood pressure (SBP) > 165 mmHg and/or diastolic blood pressure (DBP) > 110 mmHg during resting - Oxygen saturation (measured by pulse oximeter) during resting < 95% - Inability to stand for at least 5 minutes without an assistive device (length of dance game) - History of bone fracture or significant other systemic disease or surgery in the last six months |
Country | Name | City | State |
---|---|---|---|
United States | University of Illinois at Chicago | Chicago | Illinois |
Lead Sponsor | Collaborator |
---|---|
University of Illinois at Chicago | National Institute on Aging (NIA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility of a 10-week Virtual reality-based dance training: questionnaire | Feasibility of this pilot study will be determined by a feasibility questionnaire based on the ITC-Sense of Presence Inventory questionnaire. The ITC-Sense of Presence Inventory Questionnaire consists of questions and statements about the feasibility of the study and will be scored from 1(strongly disagree) to 5 (strongly agree). The questionnaire comprises of inputs regarding the participants' experiences in the virtual environment including perception and sense of presence in the virtual environment and about their experiences in the VR-based dance training environment, the presence of potential side effects and their input on the design and effects of the intervention. | Week 10 | |
Primary | Compliance rate of participants to a 10-week virtual reality-based dance training | Percentage of the number of sessions completed out of a total of 30 by each participant. | End of all dance training sessions at Week 10 | |
Primary | Change in cognitive functions during single and dual tasks | Accuracy of performance to cognitive task which assesses attention, executive function and reaction time by the use of computerized Neuropsychological Battery test.
Accuracy and reaction time will also be tested by serial subtraction, letter number sequence, Trial Making Test and category naming task. Performance and cost will be evaluated during dual tasking with Serial subtraction, letter number sequence and category fluency cognitive task while walking on gait rite, performing slip and trip test and also during volitional Limits of Stability, LOS and Sensory Organization Test, SOT with NeuroCoM Balance Master. Accuracy (number of correct responses out of the total responses). Higher accuracy indicates better performance. |
Baseline at Week 0, Mid-intervention at week 5, post-intervention week 11 and Follow-up at week 14 | |
Primary | Change in incidence of falls | Change in the number of falls over 14 weeks will be assessed by the Fall Incidence Questionnaire. This fall questionnaire ascertains the number of falls experienced by participants over 14 weeks of the study. Reduction in the number of falls is a good indication of effectiveness of the intervention. | Baseline at week 0 and Follow-up at week 14 | |
Primary | Change in end point excursion | It is the magnitude of a self-initiated movement (i.e., how far he/she wills to reach a target) without taking a step or losing balance measured in percentage under single and dual-task conditions. Higher values indicate better performance. | Baseline at week 0, mid-intervention at week 5, post-intervention at week 11 and follow-up test at week 14 | |
Primary | Change in Movement velocity | It is the average speed of center of gravity movement during intentional movement measured in degrees per second under single and dual-task conditions. Higher values indicate better performance. | Baseline at week 0, mid-intervention at week 5, post-intervention at week 11 and follow-up test at week 14 | |
Primary | Change in maximum excursion | It is the actual magnitude of a self-initiated movement (i.e., how far did he/she actually reach a target) without taking a step or losing balance measured in percentage under single and dual-task conditions. Higher values indicate better performance. | Baseline at week 0, mid-intervention at week 5, post-intervention at week 11 and follow-up test at week 14 | |
Primary | Change in directional control | It is the quality of a self-initiated movement (i.e., amount of movement actually exhibited towards the target to the amount of extraneous movement away from the target) measured in percentage under single and dual-task conditions. Higher values indicate better performance. | Baseline at week 0, mid-intervention at week 5, post-intervention at week 11 and follow-up test at week 14 | |
Primary | Change in postural stability during reactive balance control (single and dual-task) | Reactive stability balance, in terms of center of mass position and velocity during slips and trips will be assessed with ActiveStep Treadmill equipment and inertial sensors. Postural stability can be defined as simultaneous control of center of mass (COM) position and velocity during slip-like or trip like perturbation relative to the rear edge of base of support (rear heel). The position is normalized with the individual's foot length, and velocity by square root of gravitational acceleration and individual's body height. Larger values indicate greater stability. | Baseline at week 0, mid-intervention at week 5, post-intervention at week 11 and follow-up test at week 14 | |
Primary | Change in step length | Step length (meters), which is a determinant of fall will be assessed with Gaitrite and inertial sensors. | Baseline at week 0, mid-intervention at week 5, post-intervention at week 11 and follow-up test at week 14 | |
Primary | Change in gait speed | Gait speed (meters per second), which is determinant of fall will be assessed with Gaitrite and inertial sensors. | Baseline at week 0, mid-intervention at week 5, post-intervention at week 11 and follow-up test at week 14 | |
Primary | Change in cadence | Cadence (steps per minute), which is determinant of fall will be assessed with Gaitrite and inertial sensors. | Baseline at week 0, mid-intervention at week 5, post-intervention at week 11 and follow-up test at week 14 | |
Secondary | Change in Blood pressure (mmHg) | Blood pressure will be monitored during the course of the dance training in order to determine if there is any change in systolic or diastolic blood pressure. Change in heart rate will also be monitored in order to determine consistency in its variability, Heart rate variability, HRV. | Baseline at week 0, mid-intervention at week 5, post-intervention at week 11 and follow-up test at week 14 | |
Secondary | Change in heart rate (beats per minute, bpm) | Change in heart rate will also be monitored in order to determine consistency in its variability, Heart rate variability, HRV. | Baseline at week 0, mid-intervention at week 5, post-intervention at week 11 and follow-up test at week 14 | |
Secondary | Change in physical activity level (step count) | Change in step count before, during and after dance training will assessed by use of physical activity application (Health app on iPhone or Fit on Android) installed on smart phone. We shall also corroborate this data by assessing step count and other daily activities with Physical Activity Scale for the Elderly (PASE). Physical Activity Scale for the Elderly uses frequency, duration, and intensity level of activity over the previous week to assign a score, ranging from 0 to 793, with higher scores indicating greater physical activity. | Baseline at week 0, mid-intervention at week 5, post-intervention at week 11 and follow-up test at week 14 | |
Secondary | Change in distance covered in Six-minute walk test (6MWT) | Change in distance (in meters) covered during the performance of a 6MWT. The 6MWT assesses aerobic capacity and endurance of participants, with a normalized distance for older adult set between 392 and 572 meters. | Baseline at week 0, mid-intervention at week 5, post-intervention at week 11 and follow-up test at week 14 | |
Secondary | Change in time taken to complete Timed-Up and Go (TUG) | Change in time (in seconds) taken to complete TUG will provide us information about participants' mobility and balance statuses, as well fall risk. A score of between 7 and 12 seconds will be considered as the normal time for older adults to complete a TUG. | Baseline at week 0, mid-intervention at week 5, post-intervention at week 11 and follow-up test at week 14 | |
Secondary | Berg Balance scale | Assess static and dynamic balance. This scale consists of the participant transferring from one chair to another, reaching forward, stepping up and down from a stepping stool, standing with eyes closed and open, one leg standing. It is a 14-item scale with each item score ranging from 0-4. Performance on the scale will be calculated on a total of 56. Less than 45 will indicate greater risk of falling. | Baseline at week 0, mid-intervention at week 5, post-intervention at week 11 and follow-up test at week 14 | |
Secondary | Change in fall incidence in the home and community setting | At 4-week follow-up session, change in fall incidence will be assessed by Fall Incidence Questionnaire. This questionnaire determines the number of falls encountered by participants over the course of 14. | Follow-up test at week 14 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A |